Main subject:

Keywords:

What are the latest drug market trends and what are the factors driving them? What drugs are causing the most concern today? What are the most recent developments in drug prevention, treatment and policy? These, and other, questions will be explored by the EU drugs agency (EMCDDA) on 7 June in its annual overview of the European drug situation.

The European Drug Report 2018: Trends and Developments, provides a comprehensive analysis of patterns emerging across the 28 EU Member States, Turkey and Norway. In print and pdf in 24 languages, the report examines: drug supply and the market; drug use prevalence and trends; and drug-related harms and responses to them. Accompanying the report will be the 2018 Statistical Bulletin, containing the European dataset underpinning the analysis.

The report will be complemented by 30 Country Drug Reports, presenting summaries of national drug phenomena (EU 28, Turkey and Norway). Developed by the EMCDDA, in cooperation with the Reitox national focal points, these online reports cover: drug use and public health problems; drug policy and responses and drug supply.

Launch details

Date: 7 June 2018

Time: 10:00 Central European Time/CET (09:00 Western European Time/WET/Lisbon).

Interviews: EMCDDA representatives will be available on the day of the launch to answer journalistsʼ questions. Across Europe, staff at the Reitox national focal points will answer country-specific queries (interview details available via the link below).

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU’s decentralised agencies. Read more >>